RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Inhibition of Ferroptosis Enhances Anticancer Effect of Magnetized-Natural Killer Cell Therapy.
Inhibition of Ferroptosis Enhances Anticancer Effect of Magnetized-Natural Killer Cell Therapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
自然杀伤(NK)细胞疗法是一种有前景的肿瘤免疫治疗方法;然而,其临床疗效受到NK细胞向实体瘤迁移和浸润能力低的限制。因此,我们采用细胞磁化技术,通过将NK细胞与ferucarbotran(一种超顺磁性氧化铁纳米颗粒)共孵育,增强NK细胞在肿瘤部位的聚集。
我们观察到NK细胞可以被磁化,但由于脂质过氧化物积累,其活力和细胞毒性功能显著降低。然而,使用铁死亡抑制剂处理可通过抑制脂质过氧化物积累恢复NK细胞功能。
此外,NK细胞磁化降低了关键抗铁死亡蛋白的表达,提示磁化诱导了铁死亡。进一步地,在B16F10黑色素瘤小鼠模型中,将磁化NK细胞和铁死亡抑制剂转移至荷瘤小鼠,随后在肿瘤部位施加钕磁铁以引导NK细胞聚集。免疫组织化学分析证实肿瘤组织中NK细胞聚集增加,提示磁化改善了NK细胞向肿瘤的递送。磁化NK细胞联合铁死亡抑制剂显著抑制了肿瘤生长并延长了生存期。这些发现表明,将细胞磁化技术与铁死亡抑制剂相结合,通过改善肿瘤浸润同时保留细胞毒性功能,增强了NK细胞疗法。这种新方法可能是提高NK细胞疗法疗效的有前景的策略,尤其是对于实体瘤。
Natural killer (NK) cell therapy is a promising approach for cancer immunotherapy; however, its clinical efficacy is limited by the low migration and infiltration of NK cells into solid tumors.
Therefore, we used cell magnetization technology to enhance NK accumulation at tumor sites by incubating NK cells with ferucarbotran, a superparamagnetic iron oxide nanoparticle.
We observed that NK cells could be magnetized, but their viability and cytotoxic function were significantly reduced because of lipid peroxide accumulation.
However, treatment with the ferroptosis inhibitor restored NK cell function by inhibiting lipid peroxide accumulation.
Additionally, NK cell magnetization decreased the expression of key anti-ferroptosis proteins, suggesting that magnetization induced ferroptosis.
Furthermore, in a murine B16F10 melanoma mouse model, magnetized NK cells and ferroptosis inhibitors were transferred to tumor-bearing mice, followed by the application of a neodymium magnet to the tumor site to guide NK cell accumulation. Immunohistochemical analysis confirmed increased NK cell accumulation in the tumor tissue, suggesting that magnetization improved NK cell delivery to the tumor. Magnetized NK cells with the ferroptosis inhibitor significantly suppressed tumor growth and prolonged survival.
These findings indicate that combining cell magnetization technology with ferroptosis inhibitors enhances NK cell therapy by improving tumor infiltration while preserving the cytotoxic function. This novel approach may be a promising strategy for improving the efficacy of NK cell-based therapies, particularly for solid tumors.
MEMBER ACCOUNT
登录成功会直接打开下一页。